Zenlabs Ethica Limited
BSE: ZENLABS
Prev Close
31.56
Open Price
35.14
Volume
3,077
Today Low / High
31.07 / 35.14
52 WK Low / High
27.33 / 44.29
Range
30 - 33
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 31.11, reflecting a change of -0.45 (-1.42586%). The expected target range on the BSE is 30 - 33. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Zenlabs Ethica Limited Graph
Zenlabs Ethica Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Zenlabs Ethica Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 31.11, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 31.11 | 31.42 | 28.28 - 34.56 |
| 31.73 | 25.39 - 38.08 | ||
| 32.04 | 22.43 - 41.66 | ||
| Bearish Scenario | 31.11 | 30.80 | 27.72 - 33.88 |
| 30.49 | 24.39 - 36.59 | ||
| 30.18 | 21.12 - 39.23 |
Overview of Zenlabs Ethica Limited
ISIN
INE546F01013
Industry
Medical - Pharmaceuticals
Vol.Avg
5,617
Market Cap
202,526,722
Last Dividend
0
Official Website
IPO Date
2000-04-10
DCF Diff
-28.10
DCF
59
Financial Ratios Every Investor Needs
Stock Dividend of ZENLABS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2022-07-29 | July 29, 22 | 0.25 | 0.25 | 2022-08-01 | 2022-08-18 | |
| 2017-09-20 | September 20, 17 | 0.2381 | 0.25 | 2017-09-22 | 2017-10-27 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 51.42 Cr | 37.22 Cr | 14.20 Cr | 0.2762 | 0.00 Cr | 0.00 Cr | 1.31 Cr | 0.27 Cr | 0.41 | 2.62 Cr | 0.0052 |
| 2024-03-31 | 58.56 Cr | 43.79 Cr | 14.78 Cr | 0.2523 | 0.00 Cr | 0.20 Cr | 1.12 Cr | 0.42 Cr | 0.65 | 2.68 Cr | 0.0072 |
| 2023-03-31 | 66.89 Cr | 53.30 Cr | 13.58 Cr | 0.2031 | 0.00 Cr | 0.23 Cr | 1.78 Cr | 0.49 Cr | 0.75 | 2.46 Cr | 0.0073 |
| 2022-03-31 | 69.09 Cr | 56.39 Cr | 12.69 Cr | 0.1837 | 0.00 Cr | 0.29 Cr | 1.59 Cr | 0.78 Cr | 1.20 | 2.48 Cr | 0.0113 |
| 2021-03-31 | 56.64 Cr | 46.73 Cr | 9.91 Cr | 0.1750 | 0.03 Cr | 0.28 Cr | 1.16 Cr | 0.77 Cr | 1.18 | 1.86 Cr | 0.0135 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.79 Cr | 40.62 Cr | 30.20 Cr | 10.4250 Cr | 12.70 Cr | 10.92 Cr | 13.10 Cr | 2.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 28.1227 Cr |
| 2024-03-31 | 0.91 Cr | 40.26 Cr | 30.14 Cr | 10.1230 Cr | 14.86 Cr | 13.95 Cr | 12.00 Cr | 3.70 Cr | 0.00 Cr | 0.00 Cr | 0.70 Cr | 27.0212 Cr |
| 2023-03-31 | 0.05 Cr | 43.49 Cr | 33.79 Cr | 9.7035 Cr | 5.84 Cr | 5.79 Cr | 11.37 Cr | 5.02 Cr | 0.00 Cr | 0.00 Cr | 0.39 Cr | 29.4518 Cr |
| 2022-03-31 | 0.01 Cr | 37.90 Cr | 28.57 Cr | 9.3341 Cr | 3.90 Cr | 3.89 Cr | 8.66 Cr | 3.53 Cr | 0.00 Cr | 0.00 Cr | 0.63 Cr | 25.2037 Cr |
| 2021-03-31 | 0.09 Cr | 32.20 Cr | 23.64 Cr | 8.5642 Cr | 2.60 Cr | 2.51 Cr | 5.18 Cr | 3.51 Cr | 0.00 Cr | 0.00 Cr | 0.58 Cr | 21.4528 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.8313 Cr | 0.1350 Cr | -3.0846 Cr | 3.8137 Cr | 0.8817 Cr | 1.7867 Cr | -0.0176 Cr | 0.4279 Cr | -1.1138 Cr | 0.0000 Cr | -1.1039 Cr |
| 2024-03-31 | -9.0605 Cr | 0.1090 Cr | 8.2383 Cr | -9.0826 Cr | -0.7132 Cr | 0.9050 Cr | -0.0221 Cr | 0.4212 Cr | 10.0223 Cr | 0.0000 Cr | -0.6264 Cr |
| 2023-03-31 | 1.5199 Cr | -1.4681 Cr | 0.0603 Cr | -0.0264 Cr | 0.1121 Cr | 1.6182 Cr | -1.5463 Cr | 0.4893 Cr | 1.6057 Cr | -0.1628 Cr | -2.7135 Cr |
| 2022-03-31 | -0.3820 Cr | 0.0015 Cr | 0.3131 Cr | -0.4092 Cr | -0.0674 Cr | 1.5059 Cr | -0.0272 Cr | 1.2211 Cr | 1.1126 Cr | 0.0000 Cr | -3.4702 Cr |
| 2021-03-31 | -8.4113 Cr | 0.1541 Cr | -0.5236 Cr | -8.4129 Cr | -8.7808 Cr | 1.5733 Cr | -0.0016 Cr | 0.8600 Cr | -0.4863 Cr | 0.0000 Cr | -0.5799 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.99 Cr | 8.70 Cr | 4.28 Cr | 0.3299 | 0.34 Cr | 0.09 Cr | 0.14 | 0.70 Cr | 0.0070 |
| 2024-12-31 | 12.72 Cr | 9.40 Cr | 3.32 Cr | 0.2613 | 0.36 Cr | 0.09 Cr | 0.13 | 0.68 Cr | 0.0067 |
| 2024-09-30 | 13.35 Cr | 10.08 Cr | 3.27 Cr | 0.2453 | 0.30 Cr | 0.05 Cr | 0.08 | 0.62 Cr | 0.0039 |
| 2024-06-30 | 12.36 Cr | 9.04 Cr | 3.32 Cr | 0.2684 | 0.30 Cr | 0.04 Cr | 0.06 | 0.62 Cr | 0.0034 |
| 2024-03-31 | 15.33 Cr | 11.09 Cr | 4.24 Cr | 0.2764 | 0.46 Cr | 0.15 Cr | 0.23 | 0.78 Cr | 0.0100 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.79 Cr | 0.23 Cr | 2.02 Cr | 19.54 Cr | 13.10 Cr | 37.35 Cr | 2.29 Cr | 40.62 Cr | 30.20 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -10.26 Cr |
| 2024-09-30 | 1.40 Cr | 0.24 Cr | 1.64 Cr | 19.06 Cr | 14.00 Cr | 36.57 Cr | 2.90 Cr | 40.47 Cr | 30.20 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.93 Cr | 0.00 Cr | 0.00 Cr | 0.93 Cr | 0.00 Cr | 0.00 Cr | -10.12 Cr |
| 2024-03-31 | 0.91 Cr | 0.24 Cr | 1.15 Cr | 20.73 Cr | 12.00 Cr | 35.55 Cr | 3.70 Cr | 40.26 Cr | 30.14 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.05 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2018-10-11 | October 11, 18 | 21:20 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born:
Gender: female
Year Born:
Gender: male
Year Born: 1971
Gender: male
Year Born: 1969
FAQs about Zenlabs Ethica Limited
The CEO is Sanjeev Kumar Singal.
The current price is ₹31.11.
The range is ₹27.33-44.29.
The market capitalization is ₹20.25 crores.
The P/E ratio is 75.65.
The company operates in the Healthcare sector.
Overview of Zenlabs Ethica Limited (ISIN: INE546F01013) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹20.25 crores and an average daily volume of 5,617 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.